307 related articles for article (PubMed ID: 21812775)
1. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
2. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
Rothrock JF; Cady RK; Aurora SK; Brandes JL; Myers JA; Fox AW; Farr SJ
Curr Med Res Opin; 2011 Nov; 27(11):2185-91. PubMed ID: 21942531
[TBL] [Abstract][Full Text] [Related]
3. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
4. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S
Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
6. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
Schulman EA
Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
[TBL] [Abstract][Full Text] [Related]
7. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
Bigal M; Rapoport A; Aurora S; Sheftell F; Tepper S; Dahlof C
Headache; 2007 Apr; 47(4):475-9. PubMed ID: 17445096
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
10. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
11. Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment.
Revicki DA; Kimel M; Beusterien K; Kwong JW; Varner JA; Ames MH; Mahajan S; Cady RK
Headache; 2006 Feb; 46(2):240-52. PubMed ID: 16492233
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications for subcutaneous triptans in the acute treatment of migraine.
Erlichson K; Waight J
Curr Med Res Opin; 2012 Jul; 28(7):1231-8. PubMed ID: 22401601
[TBL] [Abstract][Full Text] [Related]
13. Predictors of adherence to triptans: factors of sustained vs lapsed users.
Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
[TBL] [Abstract][Full Text] [Related]
14. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
15. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
Landy SH; McGinnis JE; McDonald SA
Headache; 2005 Apr; 45(4):346-9. PubMed ID: 15836571
[TBL] [Abstract][Full Text] [Related]
16. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.
Landy S; Hoagland R; Hoagland NA
Headache; 2012 Jan; 52(1):133-9. PubMed ID: 21883200
[TBL] [Abstract][Full Text] [Related]
18. A review of needle-free sumatriptan injection for rapid control of migraine.
Rothrock JF; Freitag FG; Farr SJ; Smith EF
Headache; 2013 Sep; 53 Suppl 2():21-33. PubMed ID: 24024600
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
Linde M; Mellberg A; Dahlöf C
Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
[TBL] [Abstract][Full Text] [Related]
20. Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches.
Freitag FG
Expert Rev Neurother; 2011 Apr; 11(4):481-90. PubMed ID: 21469920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
